Skip to content

Opening book details…

Can I read Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children With Wilson Disease on EtoBox?

Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children With Wilson Disease by Joanna Beata Bierła; Wojciech Jańczyk; Ewa Konopka; Aldona Wierzbicka-Rucińska; Sebastian Więckowski; Łukasz Obrycki; Jędrzej Sarnecki; Ewelina Kanarek; Bożena Cukrowska; Piotr Socha is a Medicine article available to read on EtoBox.

What is Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children With Wilson Disease about?

## ABSTRACT ## Objectives: Wilson disease (WD) is a copper metabolism disorder with toxic copper accumulation in the liver leading to liver steatosis or fibrosis. In vitro studies suggest that fatty acid-binding protein 1 (L-FABP) and lipid droplet-associated protein 5 (PLIN5) may have an impact on both processes, but knowledge about these potential biomarkers is insufficient in the case of WD. Thus, the aim of this study was to determine L-FABP and PLIN5 levels in sera of WD patients in relation to liver steatosis/fibrosis. ## Methods: The final study involved 74 WD children in whom liver steatosis (WD1 subgroup, n = 28) and fibrosis (WD2 subgroup, n = 13) were assessed with the use of transient elastography. Control groups included WD children without steatosis and fibrosis (WD0 subgroup, n = 33) and healthy children (n = 75). L-FABP and PLIN5 measurements were performed in sera with the use of the immunoenzymatic method. ## Results: L-FABP was significantly higher in the WD2 subgroup, and the correlation between L-FABP concentration and liver fibrosis was confirmed statistically by regression analysis (P = 0.04) with Pearson's coefficient r = 0.24. L-FABP was significantly corre

Who reads Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children With Wilson Disease?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Joanna Beata Bierła; Wojciech Jańczyk; Ewa Konopka; Aldona Wierzbicka-Rucińska; Sebastian Więckowski; Łukasz Obrycki; Jędrzej Sarnecki; Ewelina Kanarek; Bożena Cukrowska; Piotr Socha
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2021
Language
EN
Field
Medicine (Health Sciences)

More by Joanna Beata Bierła; Wojciech Jańczyk; Ewa Konopka; Aldona Wierzbicka-Rucińska; Sebastian Więckowski; Łukasz Obrycki; Jędrzej Sarnecki; Ewelina Kanarek; Bożena Cukrowska; Piotr Socha

Browse all works by Joanna Beata Bierła; Wojciech Jańczyk; Ewa Konopka; Aldona Wierzbicka-Rucińska; Sebastian Więckowski; Łukasz Obrycki; Jędrzej Sarnecki; Ewelina Kanarek; Bożena Cukrowska; Piotr Socha